文献速递甲状腺与颈部外科围术期管理与 ERAS

甲状腺手术后全国再入院情况解读

Understanding nationwide readmissions after thyroid surgery.
PubMed 文献 · Surgery · 2018-12-10

基于2014年美国全国再入院数据库,22,654例住院甲状腺手术患者中30天再入院率为4.4%。再入院最常见诊断为矿物质代谢紊乱和低钙血症,多数再入院发生在出院后7天内。医疗保险类型、合并症评分、出院去向、住院时长及术后低钙血症与再入院 odds 增加相关。

要点

  • 甲状腺术后30天再入院率为4.4%,54.6%发生在出院后7天内。
  • 再入院最常见病因为钙及矿物质代谢紊乱(22.1%)和低钙血症(26.6%)。
  • Medicare/Medicaid保险、Elixhauser评分≥4、出院至康复机构或家庭护理、住院≥2天及术后低钙血症与再入院风险升高相关。

核心结论

  • 甲状腺手术后再入院率相对较低且多发生在术后早期。
  • 再入院最常见诊断为钙和矿物质代谢紊乱,同时也是最常见再入院原因。
  • 社会经济因素、合并症及索引住院期间并发症与非计划性再入院相关。

研究设计与样本

  • 回顾性队列研究,使用2014年美国全国再入院数据库。
  • 纳入接受住院甲状腺手术(甲状腺叶切除、部分切除、全切及胸骨下甲状腺切除)的患者共22,654例。
  • 采用多因素logistic回归控制混杂因素,分析30天再入院相关因素。

主要发现

  • 990例(4.4%)患者在30天内再入院。
  • 再入院诊断中矿物质代谢紊乱占36.0%,低钙血症占26.6%;钙相关异常为再入院首要诊断(22.1%)。
  • 54.6%的再入院发生在出院后7天内,24.6%发生在最初2天内。
  • 再入院风险增加的因素包括:Medicare保险(AOR 1.47,95%CI 1.03-2.11)、Medicaid保险(AOR 1.44,95%CI 1.04-1.99)、出院至住院后急性护理机构(AOR 2.31,95%CI 1.48-3.62)或家庭健康护理(AOR 1.78,95%CI 1.21-2.63)、Elixhauser合并症评分≥4(AOR 2.04,95%CI 1.27-3.26)、甲状腺术后住院时长≥2天(AOR 2.7,95%CI 1.9-3.82)。
  • 索引住院期间唯一与再入院风险增加相关的并发症为低钙血症(AOR 1.5,95%CI 1.1-2.06)。

关键数值与推荐

  • 30天再入院率为4.4%(990/22,654)。
  • 再入院最常见诊断:矿物质代谢紊乱36.0%,低钙血症26.6%。
  • 54.6%再入院发生在出院后7天内,24.6%在最初2天内。
  • 低钙血症并发症与再入院风险增加相关(AOR 1.5,95%CI 1.1-2.06)。

临床怎么用

  • 甲状腺术后应重点关注钙和矿物质代谢紊乱,尤其出院后第一周。
  • 对具有Medicare/Medicaid保险、高合并症评分、非家庭出院或住院≥2天的患者,可考虑加强出院后监测与随访。
  • 识别术后低钙血症并及时处理,可能有助于降低再入院风险。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 30-day readmission rate is increasingly utilized as a metric of quality that impacts reimbursement. To date, there are no nationally representative data on readmission rates after thyroid surgery. We aimed to determine national readmission rates after inpatient thyroidectomy operations and whether select clinical factors were associated with increased odds of postthyroidectomy readmission. METHODS: Using the 2014 Nationwide Readmissions Database, we identified patients undergoing inpatient thyroid surgery as defined by the International Classification of Diseases, Ninth Revision, procedure codes for thyroid lobectomy, partial thyroidectomy, complete thyroidectomy, and substernal thyroidectomy. Descriptive statistics were used to report readmission rates, most common diagnosis and causes of readmission, and timing of presentation after discharge. Multivariable logistic regression models controlling for potential confounders were used to determine whether select factors were associated with 30-day readmission. RESULTS: A total of 22,654 patients underwent inpatient thyroid surgery during the study period, 990 of whom (4.4%) were readmitted within 30 days. Among these, the most common diagnoses during readmission were disorders of mineral metabolism and hypocalcemia, accounting for 36.0% and 26.6% of readmissions, respectively. This held true regardless of the apparent indication for thyroid surgery (goiter, cancer, or thyroid function disorder) or timing of readmission after discharge. Calcium-related abnormalities were the top diagnoses at readmissions (22.1%). Most readmissions (54.6%) occurred within 7 days of discharge, with 24.6% within the first 2 days Factors associated with an increased odds of readmission included having Medicare (adjusted odds ratio [AOR] 1.47 and 95% confidence interval [CI] 1.03-2.11) or Medicaid insurance (AOR 1.44 [CI 1.04-1.99]), being discharged to inpatient post acute care (AOR 2.31 [CI 1.48-3.62]) or to home health care (AOR 1.78 [CI 1.21-2.63]), having an Elixhauser comorbidity score ≥ 4 (AOR 2.04 [CI 1.27-3.26]), and a duration of stay ≥2 days after the thyroid surgery (AOR 2.7 [CI 1.9-3.82]). The only complication during index admission associated with increased odds of readmission was hypocalcemia (AOR 1.5 [CI 1.1-2.06]. Indications for thyroid surgery were not associated with increased odds of readmission. CONCLUSION: Readmissions after thyroid surgery are relatively low and occur early after surgery. The most common diagnoses identified on readmission were calcium and mineral metabolism disorders, which also were the most common cause of readmission. Socioeconomic factors, comorbidities, and complications during the index admissions were found to be associated with nonelective, postthyroidectomy readmissions. Recognition of these risk factors may guide the development of interventions and protocols to decrease readmissions.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Rios-Diaz AJ, Zheng R, Thibault DP, et al. Understanding nationwide readmissions after thyroid surgery. Surgery. 2018. PMID: 30545657. doi:10.1016/j.surg.2018.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。